UnitedHealth Group reported strong Q4 and full-year 2017 results, exceeding expectations with significant revenue and earnings growth. Management raised 2018 earnings guidance, expressed optimism about future growth, and highlighted strategic investments and acquisitions fueled by tax reform benefits. The positive performance across core businesses and upbeat outlook suggest a favorable short-term impact on the stock price.

[2]